Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.02. | Clinical Laserthermia Systems AB raises up to SEK 37m through a directed issue for accelerated commercialization and expansion | 1 | Cision News | ||
24.02. | Clinical Laserthermia Systems steigert Umsatz trotz Verlusten | 1 | IT BOLTWISE | ||
21.02. | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2024 | 83 | GlobeNewswire (Europe) | Summary of the year-end report (relates to the Group)Full year (01/01/2024-12/31/2024)
Net sales totaled SEK 18,783,000 (SEK 8,273,000).
Operating profit/loss totaled SEK -54,254,000 (SEK -65,933... ► Artikel lesen | |
07.02. | Clinical Laserthermia Systems AB: CLS co-founder and former CEO Lars-Erik Eriksson leaves the board of directors at his own request | 1.019 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that Lars-Erik Eriksson, co-founder, long-time board member and former CEO, is leaving the board of directors... ► Artikel lesen | |
30.01. | Clinical Laserthermia Systems AB: Data from the clinical trial using MRI-guided FLA with TRANBERG® Thermal Therapy System in patients with prostate cancer at Radboud University Medical Center (Nijmegen, NL) is now published | 1 | Cision News | ||
14.01. | Clinical Laserthermia Systems AB: CLS Recaps 2024 and Provides Outlook for 2025-26 | 462 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that, in its recap of 2024, in the first nine months of 2024 compared to the same period 2023, CLS saw... ► Artikel lesen | |
CLINICAL LASERTHERMIA SYSTEMS Aktie jetzt für 0€ handeln | |||||
09.12.24 | Clinical Laserthermia Systems AB: The Nomination Committee of Clinical Laserthermia Systems AB has been appointed in accordance with the guidelines for the Nomination Committee adopted at the Annual General Meeting on June 28, 2024. | 2 | Cision News | ||
23.10.24 | Clinical Laserthermia Systems AB: CLS focus entirely on its successful neurosurgery business positioning the company for sustainable high-margin growth with a more streamlined operation | 163 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces it will focus entirely on its successful neurosurgery business to drive sustainable high-margin growth... ► Artikel lesen | |
21.10.24 | Clinical Laserthermia Systems AB: Bulletin from the Extraordinary General Meeting on 21st of October in Clinical Laserthermia Systems AB | 2 | Cision News | ||
19.07.24 | Nasdaq Stockholm AB: New equity rights for trading, Clinical Laserthermia Systems AB TO 7 B | 406 | GlobeNewswire | At the request of Clinical Laserthermia Systems AB, Clinical Laserthermia
Systems AB equity rights will be traded on First North Growth Market as from
July 22, 2024.
Security name: Clinical Laserthermia... ► Artikel lesen | |
11.07.24 | Nasdaq Stockholm AB: New last trading day for paid subscription units (BTU) of Clinical Laserthermia Systems AB (Record Id 269640) | 350 | GlobeNewswire | At the request of Clinical Laserthermia Systems AB, the last trading day in
Clinical Laserthermia Systems AB's paid subscription units will be changed from
2024-07-12 to 2024-07-16.
Instrument:... ► Artikel lesen | |
11.06.24 | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Clinical Laserthermia Systems AB (Record Id 265418) | 542 | GlobeNewswire | With effect from June 12, 2024, the unit rights in Clinical Laserthermia
Systems AB will be traded on First North Growth Market. Trading will continue
up until and including June 20, 2024.
Instrument:... ► Artikel lesen | |
07.06.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.06.2024 | 1.506 | Xetra Newsboard | Das Instrument FKG US12776P5070 CAPRICORN E.LS-,034265734 EQUITY wird cum Kapitalmassnahme gehandelt am 07.06.2024 und ex Kapitalmassnahme am 10.06.2024 The instrument FKG US12776P5070 CAPRICORN E.LS-... ► Artikel lesen | |
29.05.24 | Clinical Laserthermia Systems AB: CLS publishes interim report January - March 2024 | 197 | GlobeNewswire (Europe) | CLS publishes interim report January - March 2024Summary of the interim report (relates to the Group)Three months (01/01/2024-03/31/2024)
Net sales totaled SEK 3,140,000 (SEK 587,000).
Profit/loss... ► Artikel lesen | |
25.04.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 25.04.2024 | 551 | Xetra Newsboard | The following instruments on XETRA do have their first trading 25.04.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 25.04.2024
Aktien
1 CA09263C1068 Blackrock Inc. CDR
2... ► Artikel lesen | |
24.04.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.04.2024 | 522 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 24.04.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.04.2024.ISIN NameCA56450P2008 MANTARO... ► Artikel lesen | |
24.04.24 | XFRA ISIN CHANGE | 562 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS03815U3005 Applied DNA Sciences Inc. 24.04.2024 US03815U4094 Applied DNA Sciences Inc. 25.04.2024 Tausch 20:1CA56450P2008 First... ► Artikel lesen | |
24.04.24 | Nasdaq Stockholm AB: Reverse Split and Change of ISIN for Clinical Laserthermia Systems AB | 416 | GlobeNewswire | Referring to the bulletin from Clinical Laserthermia Systems AB's annual
general meeting, held on April 12, 2024, the company will carry out a reverse
stock split in relations 1:200. The share will... ► Artikel lesen | |
24.04.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 24.04.2024 | 922 | Xetra Newsboard | Das Instrument IQCY LU2023679256 LIF-SM.CIT.ETF DLA ETF wird cum Kapitalmassnahme gehandelt am 24.04.2024 und ex Kapitalmassnahme am 25.04.2024 The instrument IQCY LU2023679256 LIF-SM.CIT.ETF DLA ETF... ► Artikel lesen | |
09.04.24 | Clinical Laserthermia Systems Americas, Inc.: CLS Americas Announces 2nd Order of TRANBERG Focal Laser Ablation Accessories Placed by the National Institutes of Health Clinical Center | 161 | GlobeNewswire (Europe) | LOS ANGELES, April 09, 2024 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today announced... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
GERRESHEIMER | 80,25 | +4,22 % | Gerresheimer-Aktie verliert 2,81 Prozent (77,90 €) | Am deutschen Aktienmarkt liegt der Anteilsschein von Gerresheimer derzeit im Minus. Der jüngste Kurs betrug 77,90 Euro. An der Börse liegt die Aktie von Gerresheimer zur Stunde im Minus. Das Wertpapier... ► Artikel lesen | |
FRESENIUS | 39,650 | -0,03 % | Fresenius SE & Co. KGaA-Aktie: Kurs mit wenig Bewegung (39,35 €) | Wenig Kursbewegung derzeit bei der Fresenius SE & Co. KGaA-Aktie . Der jüngste Kurs betrug 39,35 Euro. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich zur Stunde der Kurs der... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 52,46 | +0,42 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 58 auf 60 Euro angehoben, aber die Einstufung auf "Neutral" belassen. Analyst Richard... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 43,510 | -1,23 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
10.03.2025... ► Artikel lesen | |
CARL ZEISS MEDITEC | 66,65 | +3,98 % | DAX-Check: Carl Zeiss Meditec, Heidelberg Materials, Hypoport, LEG Immobilien, Rheinmetall, Traton | Zum Wochenschluss ging es an der Frankfurter Börse bergab, da Anleger nach einer turbulenten Handelswoche Gewinne mitnahmen. Der DAX, der am Vortag mit 23.475 Punkten noch ein neues Rekordhoch erreicht... ► Artikel lesen | |
GENEDX | 97,41 | 0,00 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
INTUITIVE SURGICAL | 440,00 | -1,10 % | Die Intuitive Surgical-Aktie heute schwach: Kurs rutscht deutlich ab! (456,1054 €) | Die Aktie von Intuitive Surgical zählt am Montag zu den großen Verlierern an der Börse. Das Wertpapier verliert deutlich an Wert. Ein Verlust auf zwischenzeitlich 494,40 US-Dollar beschert der Aktie... ► Artikel lesen | |
HIMS & HERS HEALTH | 30,690 | +0,66 % | Hims & Hers Stock Gains 8.6% in Three Months: How to Play It? | ||
UNITEDHEALTH | 449,30 | +0,09 % | Dividendenbekanntmachungen (10.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADAIRS LIMITED AU000000ADH2 0,065 AUD 0,0378 EUR ADEIA INC US00676P1075 0,05 USD 0,0461 EUR ADVANSIX INC US00773T1016 0,16 USD 0... ► Artikel lesen | |
ECKERT & ZIEGLER | 56,55 | -0,70 % | Eckert&Ziegler mit HORROR-MELDUNG: Experten setzen SCHOCKIERENDES Kursziel - Bitte beachten wegen Montag! | ||
PROCEPT BIOROBOTICS | 58,03 | +0,31 % | PROCEPT BioRobotics Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada | ||
MEDTRONIC | 85,44 | +0,19 % | Research and Markets: Europe Implantable Loop Recorders Market Analysis and Forecast, 2025-2035 with Medtronic, Abbott Laboratories, Boston Scientific, and BIOTRONIK Leading - ResearchAndMarkets.com | The "Europe Implantable Loop Recorders Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.
Key players in the market are Medtronic PLC., Abbott... ► Artikel lesen | |
THERMO FISHER | 476,15 | -0,75 % | Dividendenbekanntmachungen (14.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,3065 EUR ACADIAN ASSET MANAGEMENT INC US10948W1036 0,01 USD 0,0092 EUR ACCO... ► Artikel lesen | |
ESSILORLUXOTTICA | 262,90 | +0,54 % | UBS stuft EssilorLuxottica auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für EssilorLuxottica auf "Neutral" mit einem Kursziel von 266 Euro belassen. Analystin Susy Tibaldi beschäftigte sich in einer... ► Artikel lesen | |
HYPERFINE | 1,265 | +38,12 % | Hyperfine teams up with NVIDIA to advance AI-powered image reconstruction |